148 related articles for article (PubMed ID: 7553603)
21. Induction of cytostasis in mammary carcinoma cells treated with the anticancer agent perillyl alcohol.
Shi W; Gould MN
Carcinogenesis; 2002 Jan; 23(1):131-42. PubMed ID: 11756234
[TBL] [Abstract][Full Text] [Related]
22. The inhibition of protein prenyltransferases by oxygenated metabolites of limonene and perillyl alcohol.
Gelb MH; Tamanoi F; Yokoyama K; Ghomashchi F; Esson K; Gould MN
Cancer Lett; 1995 May; 91(2):169-75. PubMed ID: 7767906
[TBL] [Abstract][Full Text] [Related]
23. Structure-activity relationships among monoterpene inhibitors of protein isoprenylation and cell proliferation.
Crowell PL; Ren Z; Lin S; Vedejs E; Gould MN
Biochem Pharmacol; 1994 Apr; 47(8):1405-15. PubMed ID: 8185648
[TBL] [Abstract][Full Text] [Related]
24. A phase II trial of daily perillyl alcohol in patients with advanced ovarian cancer: Eastern Cooperative Oncology Group Study E2E96.
Bailey HH; Levy D; Harris LS; Schink JC; Foss F; Beatty P; Wadler S
Gynecol Oncol; 2002 Jun; 85(3):464-8. PubMed ID: 12051875
[TBL] [Abstract][Full Text] [Related]
25. Induction of apoptosis in liver tumors by the monoterpene perillyl alcohol.
Mills JJ; Chari RS; Boyer IJ; Gould MN; Jirtle RL
Cancer Res; 1995 Mar; 55(5):979-83. PubMed ID: 7867007
[TBL] [Abstract][Full Text] [Related]
26. Activation of the transforming growth factor beta signaling pathway and induction of cytostasis and apoptosis in mammary carcinomas treated with the anticancer agent perillyl alcohol.
Ariazi EA; Satomi Y; Ellis MJ; Haag JD; Shi W; Sattler CA; Gould MN
Cancer Res; 1999 Apr; 59(8):1917-28. PubMed ID: 10213501
[TBL] [Abstract][Full Text] [Related]
27. Perillyl alcohol inhibits a calcium-dependent constitutive nuclear factor-kappaB pathway.
Berchtold CM; Chen KS; Miyamoto S; Gould MN
Cancer Res; 2005 Sep; 65(18):8558-66. PubMed ID: 16166337
[TBL] [Abstract][Full Text] [Related]
28. Phase I study of perillyl alcohol in patients with refractory malignancies.
Murren JR; Pizzorno G; DiStasio SA; McKeon A; Peccerillo K; Gollerkari A; McMurray W; Burtness BA; Rutherford T; Li X; Ho PT; Sartorelli A
Cancer Biol Ther; 2002; 1(2):130-5. PubMed ID: 12170772
[TBL] [Abstract][Full Text] [Related]
29. A phase I trial of perillyl alcohol in patients with advanced solid tumors.
Azzoli CG; Miller VA; Ng KK; Krug LM; Spriggs DR; Tong WP; Riedel ER; Kris MG
Cancer Chemother Pharmacol; 2003 Jun; 51(6):493-8. PubMed ID: 12695855
[TBL] [Abstract][Full Text] [Related]
30. In Vivo Anti-Tumor Activity and Toxicological Evaluations of Perillaldehyde 8,9-Epoxide, a Derivative of Perillyl Alcohol.
Andrade LN; Amaral RG; Dória GA; Fonseca CS; da Silva TK; Albuquerque Júnior RL; Thomazzi SM; do Nascimento LG; Carvalho AA; de Sousa DP
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26742032
[TBL] [Abstract][Full Text] [Related]
31. Clinical trials referral resource. Clinical trials with perillyl alcohol.
Zweibel J; Ho P; Sepelak SB; Saunders J; Cheson BD; Nelson A
Oncology (Williston Park); 1997 Dec; 11(12):1817, 1820. PubMed ID: 9436188
[No Abstract] [Full Text] [Related]
32. Cytotoxic, Antiproliferative and Apoptotic Effects of Perillyl Alcohol and Its Biotransformation Metabolite on A549 and HepG2 Cancer Cell Lines.
Oturanel CE; Kıran İ; Özşen Ö; Çiftçi GA; Atlı Ö
Anticancer Agents Med Chem; 2017; 17(9):1243-1250. PubMed ID: 28044940
[TBL] [Abstract][Full Text] [Related]
33. Cancer chemoprevention and therapy by monoterpenes.
Gould MN
Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):977-9. PubMed ID: 9255590
[TBL] [Abstract][Full Text] [Related]
34. Growth inhibition of rat liver epithelial tumor cells by monoterpenes does not involve Ras plasma membrane association.
Ruch RJ; Sigler K
Carcinogenesis; 1994 Apr; 15(4):787-9. PubMed ID: 8149498
[TBL] [Abstract][Full Text] [Related]
35. Phase I pharmacokinetic trial of perillyl alcohol (NSC 641066) in patients with refractory solid malignancies.
Hudes GR; Szarka CE; Adams A; Ranganathan S; McCauley RA; Weiner LM; Langer CJ; Litwin S; Yeslow G; Halberr T; Qian M; Gallo JM
Clin Cancer Res; 2000 Aug; 6(8):3071-80. PubMed ID: 10955786
[TBL] [Abstract][Full Text] [Related]
36. Induction of AP-1 activity by perillyl alcohol in breast cancer cells.
Satomi Y; Miyamoto S; Gould MN
Carcinogenesis; 1999 Oct; 20(10):1957-61. PubMed ID: 10506111
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of active drug metabolites after oral administration of perillyl alcohol, an investigational antineoplastic agent, to the dog.
Phillips LR; Malspeis L; Supko JG
Drug Metab Dispos; 1995 Jul; 23(7):676-80. PubMed ID: 7587953
[TBL] [Abstract][Full Text] [Related]
38. Perillyl Alcohol Inhibits Breast Cell Migration without Affecting Cell Adhesion.
Wagner JE; Huff JL; Rust WL; Kingsley K; Plopper GE
J Biomed Biotechnol; 2002; 2(3):136-140. PubMed ID: 12488578
[TBL] [Abstract][Full Text] [Related]
39. Failure to demonstrate chemoprevention by the monoterpene perillyl alcohol during early rat hepatocarcinogenesis: a cautionary note.
Löw-Baselli A; Huber WW; Käfer M; Bukowska K; Schulte-Hermann R; Grasl-Kraupp B
Carcinogenesis; 2000 Oct; 21(10):1869-77. PubMed ID: 11023545
[TBL] [Abstract][Full Text] [Related]
40. Cell cycle arrest by the isoprenoids perillyl alcohol, geraniol, and farnesol is mediated by p21(Cip1) and p27(Kip1) in human pancreatic adenocarcinoma cells.
Wiseman DA; Werner SR; Crowell PL
J Pharmacol Exp Ther; 2007 Mar; 320(3):1163-70. PubMed ID: 17138864
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
